Daily FNArena News - Australia

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.

GUD Holdings is confident organic growth in its automotive business will return to historical levels in the second half. Several brokers prefer to wait and see.

Unplanned outages at the ammonia and phosphate plants have affected sentiment toward Incitec Pivot, while fertiliser and explosives prices are key going forward.

While the Australasian market remains benign, Credit Corp has set its sights on US expansion, where it is now buying debt ledgers from the largest seller in that market.

Steven Everett of Belvedere Share Managers shares his perceptions of the changes being made by new management at G8 Education.

The core sleep therapy business of ResMed remains solid but brokers and the market have judged the stock harshly as details emerge regarding the cost of acquisitions.

The market opportunity for Netwealth is substantial and brokers are prepared to look through the negative flows in the December quarter, although valuation remains a sticking point.

Increased volatility in markets and downgraded economic growth expectations are a positive backdrop for defensive names among A-REITs. Brokers embark on a round of stock picking.

A host of items are expected to negatively affect BHP Group’s first half profit, although most brokers acknowledge there is still enough momentum to meet full year guidance.

Record gold production was a highlight for Saracen Mineral Holdings in the December quarter, although several brokers consider the stock overpriced.